about
Scalable Surface Area Characterization by Electrokinetic Analysis of Complex Anion AdsorptionThe effects of dentin bonding agent formulas on their polymerization quality, and together with tooth tissues on their microleakage and shear bond strength: an explorative 3-step experimentThe effects of light curing units and environmental temperatures on C 000000000000 000000000000 000000000000 111111111111 000000000000 111111111111 000000000000 000000000000 000000000000 C conversion of commercial and experimental bonding agents.Effect of polyunsaturated fatty acids (PUFAs) on airway epithelial cells' tight junction.Curcumin as a wound healing agent.A mini-review on novel intraperiodontal pocket drug delivery materials for the treatment of periodontal diseases.Cell-based therapies for the treatment of idiopathic pulmonary fibrosis (IPF) disease.Antibiotic eluting clay mineral (Laponite®) for wound healing application: an in vitro study.The use of fatty acids as absorption enhancer for pulmonary drug delivery.The effect of non-specific tight junction modulators on the transepithelial transport of poorly permeable drugs across airway epithelial cells.Combination of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate for the treatment of inflammatory lung diseases: An in vitro studyInvestigation into physical–chemical variables affecting the manufacture and dissolution of wet-milled clarithromycin nanoparticlesStrategies to Enhance Drug Absorption via Nasal and Pulmonary RoutesSynthesis of stabilized hydroxyapatite nanosuspensions for enamel caries remineralizationCo-Spray-Dried Urea Cross-Linked Hyaluronic Acid and Sodium Ascorbyl Phosphate as Novel Inhalable Dry Powder FormulationClinical side effects of continuous positive airway pressure in patients with obstructive sleep apnoeaIn vitro characterization of physico-chemical properties, cytotoxicity, bioactivity of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate nasal powder formulationThe potential to treat lung cancer via inhalation of repurposed drugsLung-on-a-chip: the future of respiratory disease models and pharmacological studies
P50
Q30048777-F1AA78CD-AE84-44D0-A57E-F21D4DC86B46Q34412311-E9AFA569-8340-4911-A548-83A3D2494788Q34469878-35591110-29DC-45A5-852A-77DCC6AF221EQ36084324-17FF8848-F571-4294-B3D0-CA4D07270F35Q38247094-73DB6306-556D-406B-99DD-5D9964F6458DQ38383065-96D6B13F-7A29-4F4B-B13F-9F35F6F45783Q38642870-FA03B128-6103-4122-AA80-424A2FC9454EQ46866326-DBEF9B7E-A39B-4F3F-A427-A8522DE81903Q49845744-32E8F507-2A33-4007-B173-87D1659B60DFQ51423431-CEB01786-2A4D-4114-8DEE-F4CDD1E1C905Q62603610-904F6BC0-ADDA-4267-8E6B-0435313305ABQ62603687-84E1D386-2067-4A39-9F0D-5964610AACEFQ64109049-EFB69A9F-0F4D-4E2C-9A93-16EB1A5F7851Q88874310-D9BAEC6B-7657-48AC-BF5D-6989E261F912Q90153799-55818D94-E938-43B9-B55C-004389407DFDQ90649429-AF8E466C-7CC2-4222-ABDA-B54622008BACQ91120978-3F012D8B-F58D-4DEA-A946-DC7241C4EB57Q91317653-B5939D7D-6D87-481F-99A6-2E95823FC9B3Q92449055-1D88360C-EB8C-4F6F-86E8-C70E817B79C9
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Maliheh Ghadiri
@en
Maliheh Ghadiri
@nl
type
label
Maliheh Ghadiri
@en
Maliheh Ghadiri
@nl
prefLabel
Maliheh Ghadiri
@en
Maliheh Ghadiri
@nl
P31
P496
0000-0002-7371-9505